Version 2.77

Description

Cefdinir (marketed by Abbott Laboratories under the brand name Omnicef) is a semi-synthetic, broad-spectrum antibiotic in the third generation of the cephalosporin class, proven effective for common bacterial infections of the ear, sinus, throat, and skin. It was approved by the U.S. Food and Drug Administration (FDA) in December 1997. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Cefdinir

Basic Part Properties

Part Display Name
Cefdinir
Part Type
Component (Describes the core component or analyte measured)
Created On
2000-05-04
Construct for LOINC Short Name
Cefdinir

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP19960-1
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP19960-1

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 头孢地尼
fr-CA French (Canada) Cefdinir
et-EE Estonian (Estonia) Tsefdiniir
es-ES Spanish (Spain) Cefdinir
it-IT Italian (Italy) Cefdinir
tr-TR Turkish (Turkey) Sefdinir
ru-RU Russian (Russian Federation) Цефдинир
nl-NL Dutch (Netherlands) cefdinir
fr-BE French (Belgium) Cefdinir